President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views concerning the COVID-19 pandemic, to steer the Federal Drug Administration.
Makary is a surgical oncologist at Johns Hopkins College and an writer. He’ll lead Trump’s well being arm underneath the steerage of Robert F. Kennedy Jr. who was tapped to move the Division of Well being and Human Companies earlier this week.
“I am confident that Dr. Makary, having dedicated his career to High-Quality, Lower-Cost Care, will restore FDA to the Gold Standard of Scientific Research, and cut the bureaucratic red tape at the Agency to make sure Americans get the Medical Cures and Treatments they deserve,” the assertion reads.
Makary has penned op-eds for the Wall Road Journal relating to vaccines for 5-year-olds and and herd immunity in 2021 in the course of the COVID-19 pandemic.
In a 2021 opinion piece for The Hill, Makary slammed the FDA for pausing the rollout of the Johnson & Johnson vaccine in the course of the pandemic because of considerations about blood clots. He described the regulatory physique’s determination making as “erratic” and missing urgency.
“We need better medical leadership,” he wrote on the time.
Up to date 8:53 p.m.
